Quarterly report pursuant to Section 13 or 15(d)

Basis of Presentation and Significant Accounting Policies (Details Narrative)

v3.10.0.1
Basis of Presentation and Significant Accounting Policies (Details Narrative)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2017
USD ($)
Sep. 30, 2016
USD ($)
Sep. 30, 2017
USD ($)
Breathlyzers
Sep. 30, 2016
USD ($)
Dec. 31, 2016
USD ($)
Allowances for doubtful accounts for trade receivables $ (192,435)   $ (192,435)   $ (1,010,196)
Bad debt expenses $ 1,299,609 47,741 $ 1,153,414  
Reversal of allowance for bad debts expense - related party       1,299,609  
Allowance for bad debts for external party       146,195  
Trade receivables 450,000   450,000  
Deferred revenue     27,073   18,858
Revenue recognition rebates expense 51,791 84,128 222,469 299,781  
Shipping, handling and transportation costs 13,679 12,321 47,148 42,754  
Cost of net revenue 16,148 $ 19,695 $ 63,719 $ 88,427  
Patents [Member]          
Number of patents | Breathlyzers     10    
Trade Receivable [Member]          
Concentration risk, number of customer | Breathlyzers     4    
Concentration risk percentage     76.00%    
Fulton Bank of New Jersey [Member]          
Cash 130,053   $ 130,053   67,865
Bank of America [Member]          
Cash 1,040   1,040   795
PayPal [Member]          
Cash 4,040   $ 4,040   $ 4,040
Minimum [Member]          
Normal credit terms extended to customers     30 days    
Maximum [Member]          
Normal credit terms extended to customers     90 days    
Cash, FDIC insured amount $ 250,000   $ 250,000    
Maximum [Member] | Patents [Member]          
Finite-lived intangible asset, useful life     17 years